Citation Impact
Citing Papers
Spinophilin Blocks Arrestin Actions in Vitro and in Vivo at G Protein-Coupled Receptors
2004 StandoutScienceNobel
PINK1-dependent recruitment of Parkin to mitochondria in mitophagy
2009 Standout
Bcl-2-like protein 13 is a mammalian Atg32 homologue that mediates mitophagy and mitochondrial fragmentation
2015 StandoutNobel
Essential Roles of SATB1 in Specifying T Lymphocyte Subsets
2017 StandoutNobel
Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration
2013
A role for mast cells in adenosine A3receptor‐mediated hypotension in the rat
1995
Gestational and Lactational Exposure to Atrazine via the Drinking Water Causes Specific Behavioral Deficits and Selectively Alters Monoaminergic Systems in C57BL/6 Mouse Dams, Juvenile and Adult Offspring
2014
13 reasons why the brain is susceptible to oxidative stress
2018
The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State
2005
Morphine reward in dopamine-deficient mice
2005 Nature
Orphanin FQ/nociceptin: a role in pain and analgesia, but so much more
1998
An Unbiased Expression Screen for Synaptogenic Proteins Identifies the LRRTM Protein Family as Synaptic Organizers
2009
The Ubiquitin Proteasome System in Neurodegenerative Diseases
2003 StandoutNobel
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
LRRTM2 Functions as a Neurexin Ligand in Promoting Excitatory Synapse Formation
2009 StandoutNobel
Opiate tolerance and dependence: receptors, G-proteins, and antiopiates
1998
Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor
1997
Drug Addiction, Dysregulation of Reward, and Allostasis
2001 Standout
MC4R Agonists: Structural Overview on Antiobesity Therapeutics
2018 StandoutNobel
Descending control of pain
2002 Standout
Selective control of inhibitory synapse development by Slitrk3-PTPδ trans-synaptic interaction
2012
NOW vs LATER brain circuits: implications for obesity and addiction
2015
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Oxytocin Improves “Mind-Reading” in Humans
2006 Standout
The Brain on Drugs: From Reward to Addiction
2015
Of Pesticides and Men: a California Story of Genes and Environment in Parkinson’s Disease
2016
REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
2007 Standout
Impairment of CaMKII activation and attenuation of neuropathic pain in mice lacking NR2B phosphorylated at Tyr1472
2010
A mitogen-activated protein (MAP) kinase homologue of Leishmania mexicana is essential for parasite survival in the infected host
1998
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease
2016 Standout
Therapeutic potential of β-arrestin- and G protein-biased agonists
2010 StandoutNobel
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Pharmacology of nociceptin and its receptor: a novel therapeutic target
2000
Genetic Disruption of Both Tryptophan Hydroxylase Genes Dramatically Reduces Serotonin and Affects Behavior in Models Sensitive to Antidepressants
2008
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Membrane-Tethered Monomeric Neurexin LNS-Domain Triggers Synapse Formation
2013 StandoutNobel
Autoradiographic localization of dopamine D1 and D2 receptors in rat nucleus accumbens: Resistance to differential rearing conditions
1991 Standout
Calmodulin Suppresses Synaptotagmin-2 Transcription in Cortical Neurons*
2010 StandoutNobel
Leucine-Rich Repeat Transmembrane Proteins Are Essential for Maintenance of Long-Term Potentiation
2013 StandoutNobel
Teaching old receptors new tricks: biasing seven-transmembrane receptors
2010 StandoutNobel
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
G‐protein receptor kinase 3 (GRK3) influences opioid analgesic tolerance but not opioid withdrawal
2004 StandoutNobel
Parkin-deficient Mice Exhibit Nigrostriatal Deficits but Not Loss of Dopaminergic Neurons
2003
Effects of supraspinal orphanin FQ/nociceptin
2000
Non-motor features of Parkinson disease
2017 Standout
A Brainstem-Spinal Cord Inhibitory Circuit for Mechanical Pain Modulation by GABA and Enkephalins
2017
Autoradiographic mapping of the opioid receptor-like 1 (ORL1) receptor in the brains of μ-, δ- or κ-opioid receptor knockout mice
2001
Orphanin FQ stimulates prolactin and growth hormone release in male and female rats
1998
Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases
2011
Microbial Reconstitution Reverses Maternal Diet-Induced Social and Synaptic Deficits in Offspring
2016
A Role for Brain Stress Systems in Addiction
2008
Physiological pathways regulating the activity of magnocellular neurosecretory cells
1999
Neurocircuitry of Addiction
2009 Standout
Skin β-Endorphin Mediates Addiction to UV Light
2014
Chiral Brønsted acid catalyzed Friedel–Crafts alkylation reactions
2009 Standout
The pros, cons, and many unknowns of probiotics
2019 Standout
The Leucine-Rich Repeat Superfamily of Synaptic Adhesion Molecules: LRRTMs and Slitrks
2012
NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease
2013 Standout
From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease
2010
MDGAs interact selectively with neuroligin-2 but not other neuroligins to regulate inhibitory synapse development
2012 StandoutNobel
The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions in vivo
2011 StandoutNobel
Receptors for Purines and Pyrimidines
1998 Standout
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Circuitry Underlying AntiOpioid Actions of Orphanin FQ in the Rostral Ventromedial Medulla
1997
β-Phenylethylamines and the isoquinoline alkaloids
2004
Orphanin FQ acts as an anxiolytic to attenuate behavioral responses to stress
1997
Satb1 Ablation Alters Temporal Expression of Immediate Early Genes and Reduces Dendritic Spine Density during Postnatal Brain Development
2011
Pain regulation by non-neuronal cells and inflammation
2016 StandoutScience
Vanilloid (Capsaicin) Receptors and Mechanisms
1999 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
A circadian gene expression atlas in mammals: Implications for biology and medicine
2014 Standout
β-Arrestins and Cell Signaling
2007 StandoutNobel
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Role of Leucine-Rich Repeat Proteins in the Development and Function of Neural Circuits
2011
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage
2017
Neuroligins/LRRTMs prevent activity- and Ca2+/calmodulin-dependent synapse elimination in cultured neurons
2011 StandoutNobel
The orphan opioid receptor and its endogenous ligand — nociceptin/orphanin FQ
1997
New ghrelin agonist, HM 01 alleviates constipation and L‐dopa‐delayed gastric emptying in 6‐hydroxydopamine rat model of P arkinson's disease
2014
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
1999 Standout
Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with125I-[14Tyr]-orphanin FQ binding
1999
The Interaction of Person-Affect-Cognition-Execution (I-PACE) model for addictive behaviors: Update, generalization to addictive behaviors beyond internet-use disorders, and specification of the process character of addictive behaviors
2019 Standout
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
The Molecular and Behavioral Pharmacology of the Orphanin FQ/Nociceptin Peptide and Receptor Family
2001
Cross-Dehydrogenative Coupling (CDC): Exploring C−C Bond Formations beyond Functional Group Transformations
2008 Standout
Nitrated Confined Imidodiphosphates Enable a Catalytic Asymmetric Oxa-Pictet–Spengler Reaction
2016 StandoutNobel
Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat
1999
NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory
2006 Standout
Works of Niall Murphy being referenced
Heroin-induced locomotion and mesolimbic dopamine release is unchanged in mice lacking the ORL.1 receptor gene
2002
Lack of evidence of a role for the neurosteroid allopregnanolone in ethanol-induced reward and c-fos expression in DBA/2 mice
2006
Slitrk1-deficient mice display elevated anxiety-like behavior and noradrenergic abnormalities
2008
Orphanin FQ/Nociceptin Modulation of Mesolimbic Dopamine Transmission Determined by Microdialysis
1999
Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study
2008
Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat
1998
The role of afferent inputs to supraoptic nucleus oxytocin neurons during naloxone-precipitated morphine withdrawal in the rat
1997
FosB Null Mutant Mice Show Enhanced Methamphetamine Neurotoxicity: Potential Involvement of FosB in Intracellular Feedback Signaling and Astroglial Function
2009
Orphanin FQ/nociceptin blocks acquisition of morphine place preference
1999
Involvement of NMDAR2A tyrosine phosphorylation in depression‐related behaviour
2009
Genetic dissection of medial habenula–interpeduncular nucleus pathway function in mice
2013
Intracerebroventricular orphanin FQ/Nociceptin supresses dopamine release in the nucleus accumbens of anaesthetized rats
1996
Accumbal dopamine and serotonin activity throughout acquisition and expression of place conditioning: correlative relationships with preference and aversion
2009
Endogenous Nociceptin (Orphanin FQ) Suppresses Basal Hedonic State and Acute Reward Responses to Methamphetamine and Ethanol, but Facilitates Chronic Responses
2007
Trypanosoma congolense: Developmental Regulation of Protein Kinases and Tyrosine Phosphorylation during the Life Cycle
1995
The NOP (ORL1) receptor antagonist Compound B stimulates mesolimbic dopamine release and is rewarding in mice by a non‐NOP‐receptor‐mediated mechanism
2004
Ghrelin prevents levodopa‐induced inhibition of gastric emptying and increases circulating levodopa in fasted rats
2012
Maintenance of conditioned place preferences and aversion in C57BL6 mice: effects of repeated and drug state testing
2004
A comparison of morphine‐induced locomotor activity and mesolimbic dopamine release in C57BL6, 129Sv and DBA2 mice
2001
Effects of a potassium channel opener (SDZ PCO 400) on guinea‐pig and human pulmonary airways
1992
Enkephalins, dynorphins, and β‐endorphin in the rat dorsal horn: An immunofluorescence colocalization study
2009
Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice
2004
Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.
1996
Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease
2012
Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism
2015
Dynamic Measurement of Extracellular Opioid Activity: Status Quo, Challenges, and Significance in Rewarded Behaviors
2015
Nociceptin/orphanin FQ, hedonic state and the response to abused drugs.
2004